✦ LIBER ✦

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

✍ Scribed by Fätkenheuer, Gerd; Pozniak, Anton L; Johnson, Margaret A; Plettenberg, Andreas; Staszewski, Schlomo; Hoepelman, Andy I M; Saag, Michael S; Goebel, Frank D; Rockstroh, Jürgen K; Dezube, Bruce J

Book ID: 109932775
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 163 KB
Volume: 11
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm1319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of R5 strains in multi-treate

Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection

✍ Bon, Isabella; Clò, Alberto; Borderi, Marco; Colangeli, Vincenzo; Calza, Leonard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naive Patients

✍ Marier, J.-F.; Trinh, M.; Pheng, L. H.; Palleja, S. M.; Martin, D. E. 📂 Article 📅 2011 🏛 American Society for Microbiology 🌐 English ⚖ 490 KB

Cost-Minimization Analysis of Maraviroc

Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia

✍ Pyadushkina, E.; Omelyanovsky, V.; Avxentyeva, M.; Rebrova, O.; Goryaynov, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Antiviral activity and safety of aplavir

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)

✍ P Yeni; A LaMarca; D Berger; P Cimoch; A Lazzarin; P Salvato; FM Smaill; E Teofi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Increase of R5 HIV-1 infection and CCR5

Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1

✍ K. Gotoh; M. Yoshimori; K. Kanbara; H. Tamamura; T. Kanamoto; K. Mochizuki; N. F 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 219 KB

Efficacy of intravenous immunoglobulins

Efficacy of intravenous immunoglobulins in patients with advanced HIV-1 infection. A randomized clinical study

✍ U. Brunkhorst; M. Stürner; H. Willers; H. Deicher; I. Schedel 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 688 KB